{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33744"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33744","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Toward Real-Time Potassium and Creatinine Monitoring: Development of an Optical Biosensor for Non-Invasive Detection","abstract":"Accurate and timely measurement of biochemical markers is essential for effective clinical decision-making, yet many important analytes are still monitored using intermittent laboratory testing. Potassium, a tightly regulated electrolyte critical for cardiac and neuromuscular function, can fluctuate rapidly, with both low and high levels posing serious health risks. Creatinine, an important marker of kidney function, is also typically measured using centralized laboratory assays that do not support continuous or real-time monitoring. Together, these limitations highlight an important gap in current diagnostics: the lack of simple, rapid, and accessible technologies for point-of-care or continuous biomarker monitoring. This thesis presents the development of a new class of micelle-enhanced optical biosensors designed to address these challenges. The primary focus is the detection of potassium using a sensing system based on sodium tetraphenylborate (STB) incorporated within sodium dodecyl sulfate (SDS) micelles. In this system, potassium induces controlled aggregation within the micellar environment, producing measurable turbidity changes that correlate with potassium concentration. Embedding STB within SDS micelles helped reduce the uncontrolled precipitation observed in conventional systems, improving signal stability, extending the measurable range, and enabling more reproducible detection in physiologically relevant matrices such as artificial saliva and interstitial fluid. The platform demonstrated sensitivity within clinically relevant ranges, with a limit of detection of approximately 0.4 mM and a limit of quantification of approximately 1.3 mM in artificial saliva. As a secondary objective, this work also explored the adaptability of the micelle-assisted sensing strategy for creatinine detection using citrate-capped gold nanoparticles (AuNPs). In this system, creatinine promotes nanoparticle aggregation, producing a plasmonic red shift that can be quantified using the absorbance ratio A680/A520. Incorporation of SDS micelles stabilized the aggregation process, minimized uncontrolled precipitation, and improved signal reproducibility. The creatinine sensing platform demonstrated detection within physiologically relevant concentrations, with a limit of detection of approximately 12.3 µM and a limit of quantification of approximately 41.1 µM in artificial saliva, while showing minimal interference from common ionic species. To support future translation beyond proof-of-concept experiments, a portable optical prototype device was also developed. The prototype integrates a light source, cuvette-based sample holder, and miniaturized optical detection system capable of rapidly measuring optical responses in small-volume samples. This demonstrates the feasibility of user-friendly point-of-care biochemical monitoring. Overall, this work introduces a sensing approach in which micelle-stabilized chemical interactions transform otherwise unstable aggregation processes into controlled and clinically useful optical signals. By demonstrating this concept across two clinically important biomarkers, potassium and creatinine, this research lays the groundwork for future multianalyte sensing platforms with potential applications in non-invasive diagnostics, wearable monitoring, and personalized healthcare.","abstract_html":"Accurate and timely measurement of biochemical markers is essential for effective clinical decision-making, yet many important analytes are still monitored using intermittent laboratory testing. Potassium, a tightly regulated electrolyte critical for cardiac and neuromuscular function, can fluctuate rapidly, with both low and high levels posing serious health risks. Creatinine, an important marker of kidney function, is also typically measured using centralized laboratory assays that do not support continuous or real-time monitoring. Together, these limitations highlight an important gap in current diagnostics: the lack of simple, rapid, and accessible technologies for point-of-care or continuous biomarker monitoring. This thesis presents the development of a new class of micelle-enhanced optical biosensors designed to address these challenges. The primary focus is the detection of potassium using a sensing system based on sodium tetraphenylborate (STB) incorporated within sodium dodecyl sulfate (SDS) micelles. In this system, potassium induces controlled aggregation within the micellar environment, producing measurable turbidity changes that correlate with potassium concentration. Embedding STB within SDS micelles helped reduce the uncontrolled precipitation observed in conventional systems, improving signal stability, extending the measurable range, and enabling more reproducible detection in physiologically relevant matrices such as artificial saliva and interstitial fluid. The platform demonstrated sensitivity within clinically relevant ranges, with a limit of detection of approximately 0.4 mM and a limit of quantification of approximately 1.3 mM in artificial saliva. As a secondary objective, this work also explored the adaptability of the micelle-assisted sensing strategy for creatinine detection using citrate-capped gold nanoparticles (AuNPs). In this system, creatinine promotes nanoparticle aggregation, producing a plasmonic red shift that can be quantified using the absorbance ratio A680/A520. Incorporation of SDS micelles stabilized the aggregation process, minimized uncontrolled precipitation, and improved signal reproducibility. The creatinine sensing platform demonstrated detection within physiologically relevant concentrations, with a limit of detection of approximately 12.3 µM and a limit of quantification of approximately 41.1 µM in artificial saliva, while showing minimal interference from common ionic species. To support future translation beyond proof-of-concept experiments, a portable optical prototype device was also developed. The prototype integrates a light source, cuvette-based sample holder, and miniaturized optical detection system capable of rapidly measuring optical responses in small-volume samples. This demonstrates the feasibility of user-friendly point-of-care biochemical monitoring. Overall, this work introduces a sensing approach in which micelle-stabilized chemical interactions transform otherwise unstable aggregation processes into controlled and clinically useful optical signals. By demonstrating this concept across two clinically important biomarkers, potassium and creatinine, this research lays the groundwork for future multianalyte sensing platforms with potential applications in non-invasive diagnostics, wearable monitoring, and personalized healthcare.","abstract_has_math":false,"creators":["Switchuk, Marianna"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biomedical Engineering","school":null,"contributors":[],"advisors":["Hildebrandt, Niko"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:37:46Z","subjects":["Potassium","Creatinine","Interstitial fluid","electrochemical sensing","optical sensing","point of care testing","wearable sensors","micelle-stabilized chemical interactions","gold nanoparticles","prototype for ISF sensing","real-time monitoring","non-invasive diagnostics","personalized medicine"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25514"],"render_values":[{"text":"https://doi.org/10.71548/25514","href":"https://doi.org/10.71548/25514","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33744","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33744","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33744","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Hildebrandt, Niko"]},{"key":"dc:contributor.department","label":"Department","values":["Biomedical Engineering"]},{"key":"dc:creator","label":"Author","values":["Switchuk, Marianna"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-08T17:53:20Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Potassium","Creatinine","Interstitial fluid","electrochemical sensing","optical sensing","point of care testing","wearable sensors","micelle-stabilized chemical interactions","gold nanoparticles","prototype for ISF sensing","real-time monitoring","non-invasive diagnostics","personalized medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33744","https://doi.org/10.71548/25514"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Accurate and timely measurement of biochemical markers is essential for effective clinical decision-making, yet many important analytes are still monitored using intermittent laboratory testing. Potassium, a tightly regulated electrolyte critical for cardiac and neuromuscular function, can fluctuate rapidly, with both low and high levels posing serious health risks. Creatinine, an important marker of kidney function, is also typically measured using centralized laboratory assays that do not support continuous or real-time monitoring. Together, these limitations highlight an important gap in current diagnostics: the lack of simple, rapid, and accessible technologies for point-of-care or continuous biomarker monitoring. This thesis presents the development of a new class of micelle-enhanced optical biosensors designed to address these challenges. The primary focus is the detection of potassium using a sensing system based on sodium tetraphenylborate (STB) incorporated within sodium dodecyl sulfate (SDS) micelles. In this system, potassium induces controlled aggregation within the micellar environment, producing measurable turbidity changes that correlate with potassium concentration. Embedding STB within SDS micelles helped reduce the uncontrolled precipitation observed in conventional systems, improving signal stability, extending the measurable range, and enabling more reproducible detection in physiologically relevant matrices such as artificial saliva and interstitial fluid. The platform demonstrated sensitivity within clinically relevant ranges, with a limit of detection of approximately 0.4 mM and a limit of quantification of approximately 1.3 mM in artificial saliva. As a secondary objective, this work also explored the adaptability of the micelle-assisted sensing strategy for creatinine detection using citrate-capped gold nanoparticles (AuNPs). In this system, creatinine promotes nanoparticle aggregation, producing a plasmonic red shift that can be quantified using the absorbance ratio A680/A520. Incorporation of SDS micelles stabilized the aggregation process, minimized uncontrolled precipitation, and improved signal reproducibility. The creatinine sensing platform demonstrated detection within physiologically relevant concentrations, with a limit of detection of approximately 12.3 µM and a limit of quantification of approximately 41.1 µM in artificial saliva, while showing minimal interference from common ionic species. To support future translation beyond proof-of-concept experiments, a portable optical prototype device was also developed. The prototype integrates a light source, cuvette-based sample holder, and miniaturized optical detection system capable of rapidly measuring optical responses in small-volume samples. This demonstrates the feasibility of user-friendly point-of-care biochemical monitoring. Overall, this work introduces a sensing approach in which micelle-stabilized chemical interactions transform otherwise unstable aggregation processes into controlled and clinically useful optical signals. By demonstrating this concept across two clinically important biomarkers, potassium and creatinine, this research lays the groundwork for future multianalyte sensing platforms with potential applications in non-invasive diagnostics, wearable monitoring, and personalized healthcare."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Toward Real-Time Potassium and Creatinine Monitoring: Development of an Optical Biosensor for Non-Invasive Detection"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Hildebrandt, Niko"],"dc:contributor.department":["Biomedical Engineering"],"dc:creator":["Switchuk, Marianna"],"dc:date.accessioned":["2026-10-08T17:53:20Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Accurate and timely measurement of biochemical markers is essential for effective clinical decision-making, yet many important analytes are still monitored using intermittent laboratory testing. Potassium, a tightly regulated electrolyte critical for cardiac and neuromuscular function, can fluctuate rapidly, with both low and high levels posing serious health risks. Creatinine, an important marker of kidney function, is also typically measured using centralized laboratory assays that do not support continuous or real-time monitoring. Together, these limitations highlight an important gap in current diagnostics: the lack of simple, rapid, and accessible technologies for point-of-care or continuous biomarker monitoring. This thesis presents the development of a new class of micelle-enhanced optical biosensors designed to address these challenges. The primary focus is the detection of potassium using a sensing system based on sodium tetraphenylborate (STB) incorporated within sodium dodecyl sulfate (SDS) micelles. In this system, potassium induces controlled aggregation within the micellar environment, producing measurable turbidity changes that correlate with potassium concentration. Embedding STB within SDS micelles helped reduce the uncontrolled precipitation observed in conventional systems, improving signal stability, extending the measurable range, and enabling more reproducible detection in physiologically relevant matrices such as artificial saliva and interstitial fluid. The platform demonstrated sensitivity within clinically relevant ranges, with a limit of detection of approximately 0.4 mM and a limit of quantification of approximately 1.3 mM in artificial saliva. As a secondary objective, this work also explored the adaptability of the micelle-assisted sensing strategy for creatinine detection using citrate-capped gold nanoparticles (AuNPs). In this system, creatinine promotes nanoparticle aggregation, producing a plasmonic red shift that can be quantified using the absorbance ratio A680/A520. Incorporation of SDS micelles stabilized the aggregation process, minimized uncontrolled precipitation, and improved signal reproducibility. The creatinine sensing platform demonstrated detection within physiologically relevant concentrations, with a limit of detection of approximately 12.3 µM and a limit of quantification of approximately 41.1 µM in artificial saliva, while showing minimal interference from common ionic species. To support future translation beyond proof-of-concept experiments, a portable optical prototype device was also developed. The prototype integrates a light source, cuvette-based sample holder, and miniaturized optical detection system capable of rapidly measuring optical responses in small-volume samples. This demonstrates the feasibility of user-friendly point-of-care biochemical monitoring. Overall, this work introduces a sensing approach in which micelle-stabilized chemical interactions transform otherwise unstable aggregation processes into controlled and clinically useful optical signals. By demonstrating this concept across two clinically important biomarkers, potassium and creatinine, this research lays the groundwork for future multianalyte sensing platforms with potential applications in non-invasive diagnostics, wearable monitoring, and personalized healthcare."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33744","https://doi.org/10.71548/25514"],"dc:language.iso":["en"],"dc:subject":["Potassium","Creatinine","Interstitial fluid","electrochemical sensing","optical sensing","point of care testing","wearable sensors","micelle-stabilized chemical interactions","gold nanoparticles","prototype for ISF sensing","real-time monitoring","non-invasive diagnostics","personalized medicine"],"dc:title":["Toward Real-Time Potassium and Creatinine Monitoring: Development of an Optical Biosensor for Non-Invasive Detection"],"dc:type":["Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:37:46Z"}